Yutaro Yamaoka

Potent antiviral effect of silver nanoparticles on SARS-CoV-2

Sundararaj Stanleyraj Jeremiah, Kei Miyakawa, Takeshi Morita et al. · Biochemical and Biophysical Research Communications · 2020 · 422 citations · Full text

Nanoparticles, Metal Nanoparticles, Silver Nanoparticles +4

Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection tests

Yutaro Yamaoka, Kei Miyakawa, Sundararaj Stanleyraj Jeremiah et al. · Cell Reports Medicine · 2021 · 54 citations · Full text

Viral Diagnostics, Immunology, Viral Pathogenesis +17

A panel of nanobodies recognizing conserved hidden clefts of all SARS-CoV-2 spike variants including Omicron

Ryota Maeda, Junso Fujita, Yoshinobu Konishi et al. · Communications Biology · 2022 · 48 citations · Full text

Development of Monoclonal Antibody and Diagnostic Test for Middle East Respiratory Syndrome Coronavirus Using Cell-Free Synthesized Nucleocapsid Antigen

Yutaro Yamaoka, Shutoku Matsuyama, Shuetsu Fukushi et al. · Frontiers in Microbiology · 2016 · 38 citations · Full text

Viral Diagnostics, Viral Pathogenesis, Immunology +16

Vaccine-induced humoral response against SARS-CoV-2 dramatically declined but cellular immunity possibly remained at 6 months post BNT162b2 vaccination

Hideaki Kato, Kei Miyakawa, Norihisa Ohtake et al. · Vaccine · 2022 · 37 citations · Full text